SULFUR - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for sulfur and what is the scope of patent protection?
Sulfur
is the generic ingredient in two branded drugs marketed by Poythress and Bracco, and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for sulfur.
Summary for SULFUR
US Patents: | 3 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 76 |
Patent Applications: | 33 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SULFUR at DailyMed |
Recent Clinical Trials for SULFUR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
OnLume Inc. | Early Phase 1 |
University of Wisconsin, Madison | Early Phase 1 |
RS Oncology LLC | Phase 1/Phase 2 |
US Patents and Regulatory Information for SULFUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Poythress | BENSULFOID | sulfur | POWDER;TOPICAL | 002918-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |